drugset / Trial / NCT01969656
Safety Study of an Oral Vitamin D Analog in Postmenopausal Women
Summary
Determine the safety of 2MD, a vitamin D analog, when administered orally once daily for 28 days in healthy normal postmenopausal women.
Timeline
- Start
- —
- Primary completion
- 2004-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcitriol | Small molecule | — | — |
| Subject | DP001 | Small molecule | 50 ng | Oral |
| Subject | DP001 | Small molecule | 110 ng | Oral |
| Subject | DP001 | Small molecule | 170 ng | Oral |
| Subject | DP001 | Small molecule | 220 ng | Oral |
| Subject | DP001 | Small molecule | 440 ng | Oral |